Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuo Toda

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
World Journal of Gastroenterology|January 18, 2013
Improvement of prognosis for unresectable biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Chemotherapy|September 14, 2013
A retrospective study of gemcitabine and cisplatin combination therapy as second-line treatment for advanced biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Endoscopy|January 16, 2015
Early use of double-guidewire technique to facilitate selective bile duct cannulation: the multicenter randomized controlled EDUCATION trialNaoki Sasahira, Hiroshi Kawakami, Hiroyuki Isayama, et al.
Cancer Chemotherapy and Pharmacology|August 27, 2009
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Surgical Endoscopy|October 21, 2011
Risk factors for pancreatitis following transpapillary self-expandable metal stent placementKazumichi Kawakubo, Hiroyuki Isayama, Yousuke Nakai, et al.
Journal of Medical Case Reports|June 3, 2019
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case reportChikako Shibata, Jun Kato, Nobuo Toda, et al.
Surgical Endoscopy|October 18, 2012
Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariateTsuyoshi Hamada, Yousuke Nakai, Hiroyuki Isayama, et al.
World Journal of Gastroenterology|January 7, 2015
Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Gut and Liver|February 14, 2020
Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute CholangitisSatoshi Kawamura, Yuki Karasawa, Nobuo Toda, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2013
A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
World Journal of Gastroenterology|January 18, 2013
Improvement of prognosis for unresectable biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Chemotherapy|September 14, 2013
A retrospective study of gemcitabine and cisplatin combination therapy as second-line treatment for advanced biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Endoscopy|January 16, 2015
Early use of double-guidewire technique to facilitate selective bile duct cannulation: the multicenter randomized controlled EDUCATION trialNaoki Sasahira, Hiroshi Kawakami, Hiroyuki Isayama, et al.
Cancer Chemotherapy and Pharmacology|August 27, 2009
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Surgical Endoscopy|October 21, 2011
Risk factors for pancreatitis following transpapillary self-expandable metal stent placementKazumichi Kawakubo, Hiroyuki Isayama, Yousuke Nakai, et al.
Journal of Medical Case Reports|June 3, 2019
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case reportChikako Shibata, Jun Kato, Nobuo Toda, et al.
Surgical Endoscopy|October 18, 2012
Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariateTsuyoshi Hamada, Yousuke Nakai, Hiroyuki Isayama, et al.
World Journal of Gastroenterology|January 7, 2015
Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Gut and Liver|February 14, 2020
Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute CholangitisSatoshi Kawamura, Yuki Karasawa, Nobuo Toda, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2013
A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancerTakashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, et al.
Pageof 9